(Q33664081)

28 July 2017

1 reference

title

Angiostatic treatment of neuroblastoma (English)

1 reference

28 July 2017

1 reference

Wassberg E

1

1 reference

28 July 2017

publication date

1 January 1999

1 reference

Upsala Journal of Medical Sciences

28 July 2017

published in

1 reference

28 July 2017

volume

104

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

1-24

1 reference

Tumor angiogenesis: therapeutic implications

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Antiangiogenesis as a novel therapeutic concept in pediatric oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

New perspectives in clinical oncology from angiogenesis research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Tumor angiogenesis: a physiological process or genetically determined?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Biology and genetics of human neuroblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Angiogenesis inhibition: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

TNP-470/minocycline/cytotoxic therapy: a systems approach to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Combined effects of angiostatin and ionizing radiation in antitumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Alpha v integrins as receptors for tumor targeting by circulating ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Vascular attack as a therapeutic strategy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Plasma levels of chromogranin A are directly proportional to tumour burden in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Characterization and uptake of radiolabelled meta-iodobenzylguanidine (MIBG) in a human neuroblastoma heterotransplant model in athymic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Differentiation and survival influences of growth factors in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Determination of subcutaneous tumor size in athymic (nude) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

An elementary introduction to stereology (quantitative microscopy).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

TNP-470 (AGM-1470): mechanisms of action and early clinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

TNP-470 antiangiogenic therapy for advanced murine neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Inhibition of angiogenesis in vivo by interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Biological action of leptin as an angiogenic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

Leptin, the product of Ob gene, promotes angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739909178953

10.3109/03009739909178953

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference